Viewing Study NCT00086203


Ignite Creation Date: 2025-12-24 @ 7:48 PM
Ignite Modification Date: 2025-12-28 @ 1:05 PM
Study NCT ID: NCT00086203
Status: COMPLETED
Last Update Posted: 2015-03-25
First Post: 2004-06-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Talabostat and Rituximab in Advanced Chronic Lymphocytic Leukemia (CLL)
Sponsor: Point Therapeutics
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module